Cedars-Sinai CEO Urged Regional Life Sciences Growth
Los Angeles leaders must adopt collaborative funding models to strengthen the local life sciences ecosystem.
Updated on Oct. 12, 2026 in Healthcare
Live Poll
Should regional leaders prioritize intense collaboration to grow the local life sciences industry?
Cedars-Sinai CEO Peter Slavin recently called for deeper collaboration among Los Angeles leaders to unify the regional life sciences sector. The remarks were delivered during a life sciences conference hosted by BioscienceLA in West Hollywood.
Why it matters
Slavin argued that connecting fragmented industry components in Los Angeles is necessary to maximize regional network effects. This push for collaboration aims to prevent local industry flight, drawing on lessons from the tech sector shift out of Boston in the 1980s.
Peter Slavin brings 18 years of experience as the former CEO of Massachusetts General Hospital to his role at Cedars-Sinai. The total impact of a potential Los Angeles life sciences collaborative remains unknown.
The players
Peter Slavin
Chief executive of Cedars-Sinai Health System who previously served 18 years as the chief executive of Massachusetts General Hospital.
Cedars-Sinai Health System
A major healthcare provider based in Beverly Grove that operates a life sciences accelerator and an investment portfolio.
BioscienceLA
A Culver City-based organization that supports the life sciences industry through advocacy and event hosting.
The details
The proposed strategy centers on replicating the collaborative funding models established by Boston-area life sciences leaders in the 1990s and early 2000s. Cedars-Sinai already facilitates this through its existing life sciences accelerator and investment portfolio, which focus on licensing research technology to external partners. Expanding this approach would integrate regional academic and corporate assets into a more cohesive support network.
Timeline
1980s: Boston tech sector players moved to Silicon Valley.
1990s and early 2000s: Boston life sciences leaders organized to strengthen the industry.
Sept. 29 – Oct. 2, 2026: BioscienceLA held a life sciences conference in West Hollywood.
Market Landscape
This proposal mirrors the 1990s Boston life sciences industry consolidation that successfully anchored research and capital in Massachusetts. It represents a shift toward intentional regional infrastructure development to prevent the capital flight seen in historical tech hubs.
Operators in the regional life sciences space should monitor whether local institutions move to formalize a collaborative funding framework. Tracking these institutional partnerships may reveal new opportunities for investment, grant access, or technology licensing agreements.
The takeaway
The success of regional life sciences sectors often depends on coordinated funding and resource sharing rather than isolated institutional efforts. Operators should monitor future BioscienceLA initiatives to see if a formal collaborative framework emerges for Los Angeles firms.
Further reading
Learn more about the evolving landscape of local medical innovation in the Healthcare section.
Source note: This article includes information reported by Los Angeles Business Journal.
Live Poll
Should regional leaders prioritize intense collaboration to grow the local life sciences industry?
